Bronchodilators are central in the treatment of of airways disorders. They are the mainstay of
the current management of chronic obstructive pulmonary disease (COPD) and are critical in …

Bronchodilators remain the cornerstone of the treatment of airway disorders such as asthma
and chronic obstructive pulmonary disease (COPD). There is therefore considerable interest …

Despite the passionate debate over the use of β2‐adrenoceptor agonists in the treatment of
airway disorders, these agents are still central in the symptomatic management of asthma …

A molecular imprinted polymer (MIP) was computationally designed and synthesized for the
selective extraction of salmeterol xinafoate (SLX) from human serum. In this study, semi …

Substantial evidence indicates that cigarette smoke exposure induces resistance to
glucocorticoids, the primary maintenance medication in asthma treatment. Modest evidence …

Background and objective: Studies in respiratory diseases other than chronic obstructive
pulmonary disease suggest potentially differing responses to medications among patients …

BACKGROUND: Equine obstructive pulmonary disease, also known as heaves or recurrent
airway obstruction (RAO) is a common equine pulmonary disease with some similarities to …

The term ultra-LABA indicates once-daily β2-AR agonists (abediterol, indacaterol, olodaterol
and vilanterol) that are single enantiomers of the (R)-configuration. All have a near full …

Background Beta-2 agonists are widely used in the treatment of asthma and chronic
obstructive pulmonary disease for their effect on airway smooth muscle relaxation. They also …

Intense exercise induces pronounced hyperkalemia, followed by transient hypokalemia in
recovery. We investigated whether the β2 agonist salbutamol attenuated the exercise …